SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 114 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $273,000 | -83.1% | 18,226 | -86.3% | 0.00% | -100.0% |
| Q1 2016 | $1,618,000 | -34.8% | 133,002 | -14.7% | 0.00% | 0.0% |
| Q4 2015 | $2,480,000 | +133.3% | 155,915 | +124.9% | 0.00% | – |
| Q3 2015 | $1,063,000 | -3.9% | 69,337 | +52.3% | 0.00% | – |
| Q2 2015 | $1,106,000 | -97.3% | 45,523 | -97.4% | 0.00% | -100.0% |
| Q1 2015 | $41,196,000 | -56.6% | 1,771,870 | -53.1% | 0.02% | -57.1% |
| Q4 2014 | $94,902,000 | -18.6% | 3,779,422 | +0.8% | 0.04% | -22.2% |
| Q3 2014 | $116,615,000 | +20.2% | 3,749,662 | -0.1% | 0.04% | +18.4% |
| Q2 2014 | $97,027,000 | +10.6% | 3,752,020 | -0.1% | 0.04% | +2.7% |
| Q1 2014 | $87,765,000 | -8.4% | 3,755,476 | -0.5% | 0.04% | -9.8% |
| Q4 2013 | $95,818,000 | +21.4% | 3,775,326 | -2.4% | 0.04% | +10.8% |
| Q3 2013 | $78,935,000 | -12.3% | 3,869,370 | -9.8% | 0.04% | -17.8% |
| Q2 2013 | $89,985,000 | – | 4,289,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |